What is the reason why CEIBS Medical was "hidden in the snow" by Alipay? She retired the hardest, and many similar medical funds are more stable than her. The biggest feature of her style is a lot of exits. Similar Tian Hui Fu and Golden Eagle are relatively stable. If you have Central Europe in your hand, you can take it as a long term. If the position is heavy, you can participate in the rebound. I also work in Central Europe. At present, it has lost seven or eight points and is ready to rebound a little; At the beginning of last year, it entered Central Europe. The plunge in March added another wave. Later, I continued to make a fixed investment. After the recent callback, it still earned more than 50%. Of course, it does not rule out further decline. The fund's advice is to take it for a long time, make a fixed investment with some spare money, and don't care too much about short-term fluctuations. After all, the handling fee is not cheap. If you are optimistic about the sector and trust the manager, you should calm down and make a fixed investment slowly. I believe the result will not be too bad, and certainly don't expect too much. It's not just about making money and winning money.

Recently, the medical sector has indeed adjusted back a little, and many Xiaobai who hold medical sector funds are a little anxious. Extend the holding time of the fund to more than three years, and look at the recent callback with a long-term perspective. I can say for sure that you can always hold the pharmaceutical sector safely, and even now you can add positions against the trend. Since June 65438+February last year, the Growth Enterprise Market has been falling rapidly, falling by 10- 15% for almost one month. The related GEM listed stocks fell even more, and the two core sectors were new energy and medical care. GEM has not only failed to fall, but it is also difficult for China and Europe to get out of the downward rhythm. The reason for the sharp decline is also because in 2020, the Growth Enterprise Market continued to rise and hit record highs. The corresponding funds such as new energy series, lithium batteries, semiconductors and new energy vehicles are overvalued.

Affected by the epidemic situation, from the end of 20 19 to the beginning of 2020, the medical sector has been in a continuous value-added trend until August and September of 200210. Now is the time to repair and adjust the decline. The shareholding of China Europe Medical, at least the general GEM stocks, has dropped significantly. The decline is also greater than that of listed companies in Shenzhen and Shanghai. Generally speaking, a single sector and individual stocks cannot fight against the general trend for a long time. What is the general trend? The general trend is the market, which is a bull and bear market. Back to the fund, the best performance of CEIBS 20 19 and 2020 is also due to the dividend income brought by the huge increase in the stock allocation of GEM. It is also a natural result that the growth enterprise market continues to fall at this stage.